Your browser doesn't support javascript.
loading
Incidence and risk factors for hyperkalaemia in patients treated for COVID-19 with nafamostat mesylate.
Kodama, Kentaro; Imai, Toru; Asai, Yasuo; Kozu, Yutaka; Hayashi, Kentaro; Shimizu, Tetsuo; Gon, Yasuhiro; Ootsuka, Susumu.
Afiliación
  • Kodama K; Department of Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Japan.
  • Imai T; Department of Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Japan.
  • Asai Y; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Kozu Y; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Hayashi K; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Shimizu T; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Gon Y; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Ootsuka S; Department of Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Japan.
J Clin Pharm Ther ; 47(7): 1070-1078, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35313385
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancreatitis / Tratamiento Farmacológico de COVID-19 / Hiperpotasemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancreatitis / Tratamiento Farmacológico de COVID-19 / Hiperpotasemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón